经导管主动脉瓣置换术在二叶式主动脉瓣狭窄中的应用
二叶式主动脉瓣(BAV)是最常见的先天性心脏病,患病率1%~2%,在80岁及以上接受主动脉瓣置换的患者中至少占25%,但随机对照试验将其排除。约10%的TAVR患者为BAV,FDA和CE已批准TAVR用于低危患者而不论瓣膜解剖,但国际指南仍推荐BAV患者接受外科置换。本综述总结了BAV解剖特殊性、TAVR技术挑战、现有临床证据及CT在诊断、分类和手术规划中的作用。
要点
- BAV是最常见先天性心脏病,患病率1%~2%,在80岁及以上主动脉瓣置换患者中至少占25%。
- 约10%的TAVR患者为BAV,但随机对照试验排除了BAV人群。
- FDA和CE已批准TAVR用于低危患者不论瓣膜解剖,国际指南仍推荐BAV患者外科置换。
核心结论
- TAVR适应症正向年轻低危患者扩展,BAV患者将更常被心脏团队遇到,但TAVR治疗BAV的疗效仍不确定。
- 本综述提供综合框架以理解TAVR在BAV狭窄治疗中的当前角色并指导临床决策。
研究设计与样本
- 综述文章,总结BAV解剖特殊性、TAVR技术挑战、现有临床证据及CT在诊断、分类和手术规划中的作用。
主要发现
- BAV患病率为总人口的1%~2%,在80岁及以上接受主动脉瓣置换的患者中至少占25%。
- 目前约10%接受TAVR的患者为BAV。
- 随机对照试验排除了BAV患者,而FDA和CE已批准TAVR用于低危患者不论主动脉瓣解剖。
- 国际指南推荐BAV人群接受外科瓣膜置换。
临床怎么用
- 心脏团队应关注BAV患者逐渐增多的趋势,在临床决策中权衡TAVR与外科置换。
- CT扫描可用于BAV的诊断、分类及TAVR手术规划。
局限性
- 随机对照试验排除了BAV患者,TAVR治疗BAV的临床证据有限。
- BAV解剖复杂,TAVR治疗该解剖的可行性仍不确定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
After 15 years of successive randomized, controlled trials, indications for transcatheter aortic valve replacement (TAVR) are rapidly expanding. In the coming years, this procedure could become the first line treatment for patients with a symptomatic severe aortic stenosis and a tricuspid aortic valve anatomy. However, randomized, controlled trials have excluded bicuspid aortic valve (BAV), which is the most frequent congenital heart disease occurring in 1% to 2% of the total population and representing at least 25% of patients 80 years of age or older referred for aortic valve replacement. The use of a less invasive transcatheter therapy in this elderly population became rapidly attractive, and approximately 10% of patients currently undergoing TAVR have a BAV. The U.S. Food and Drug Administration and the "European Conformity" have approved TAVR for low-risk patients regardless of the aortic valve anatomy whereas international guidelines recommend surgical replacement in BAV populations. Given this progressive expansion of TAVR toward younger and lower-risk patients, heart teams are encountering BAV patients more frequently, while the ability of this therapy to treat such a challenging anatomy remains uncertain. This review will address the singularity of BAV anatomy and associated technical challenges for the TAVR procedure. We will examine and summarize available clinical evidence and highlight critical knowledge gaps regarding TAVR utilization in BAV patients. We will provide a comprehensive overview of the role of computed tomography scans in the diagnosis, and classification of BAV and TAVR procedure planning. Overall, we will offer an integrated framework for understanding the current role of TAVR in the treatment of bicuspid aortic stenosis and for guiding physicians in clinical decision-making.
引用
- Vincent F, Ternacle J, Denimal T, et al. Transcatheter Aortic Valve Replacement in Bicuspid Aortic Valve Stenosis. Circulation. 2021. PMID: 33683945. doi:10.1161/CIRCULATIONAHA.120.048048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。